Logo image of AISX.CA

AISIX SOLUTIONS INC (AISX.CA) Stock Fundamental Analysis

TSX-V:AISX - TSX Venture Exchange - CA00956C1077 - Common Stock - Currency: CAD

0.045  +0 (+12.5%)

Fundamental Rating

0

Taking everything into account, AISX scores 0 out of 10 in our fundamental rating. AISX was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of AISX have multiple concerns. AISX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AISX had negative earnings in the past year.
In the past year AISX has reported a negative cash flow from operations.
AISX.CA Yearly Net Income VS EBIT VS OCF VS FCFAISX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 -500K -1M -1.5M -2M -2.5M

1.2 Ratios

Industry RankSector Rank
ROA -461.82%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AISX.CA Yearly ROA, ROE, ROICAISX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 -50 -100 -150 -200

1.3 Margins

AISX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AISX.CA Yearly Profit, Operating, Gross MarginsAISX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 -1K -2K -3K

More info and screens

0

2. Health

2.1 Basic Checks

AISX does not have a ROIC to compare to the WACC, probably because it is not profitable.
AISX has more shares outstanding than it did 1 year ago.
The debt/assets ratio for AISX is higher compared to a year ago.
AISX.CA Yearly Shares OutstandingAISX.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 20M 40M 60M 80M
AISX.CA Yearly Total Debt VS Total AssetsAISX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 500K 1M 1.5M

2.2 Solvency

AISX has an Altman-Z score of -77.68. This is a bad value and indicates that AISX is not financially healthy and even has some risk of bankruptcy.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -77.68
ROIC/WACCN/A
WACC8.9%
AISX.CA Yearly LT Debt VS Equity VS FCFAISX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 1M -1M -2M

2.3 Liquidity

A Current Ratio of 0.33 indicates that AISX may have some problems paying its short term obligations.
A Quick Ratio of 0.33 indicates that AISX may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.33
Quick Ratio 0.33
AISX.CA Yearly Current Assets VS Current LiabilitesAISX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 200K 400K 600K 800K 1M

More info and screens

0

3. Growth

3.1 Past

AISX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.96%, which is quite impressive.
AISX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -49.57%.
EPS 1Y (TTM)29.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.42%
Revenue 1Y (TTM)-49.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AISX.CA Yearly Revenue VS EstimatesAISX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 20K 40K 60K 80K 100K
AISX.CA Yearly EPS VS EstimatesAISX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

AISX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AISX.CA Price Earnings VS Forward Price EarningsAISX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AISX.CA Per share dataAISX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0 -0.01 -0.01

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AISX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AISIX SOLUTIONS INC

TSX-V:AISX (3/7/2025, 7:00:00 PM)

0.045

+0 (+12.5%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners14.25%
Ins Owner ChangeN/A
Market Cap5.13M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -461.82%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4.8%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.33
Quick Ratio 0.33
Altman-Z -77.68
F-Score1
WACC8.9%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.42%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-49.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.16%
OCF growth 3YN/A
OCF growth 5YN/A